BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24745989)

  • 1. The SLC37 family of sugar-phosphate/phosphate exchangers.
    Chou JY; Mansfield BC
    Curr Top Membr; 2014; 73():357-82. PubMed ID: 24745989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SLC37 family of phosphate-linked sugar phosphate antiporters.
    Chou JY; Sik Jun H; Mansfield BC
    Mol Aspects Med; 2013; 34(2-3):601-11. PubMed ID: 23506893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.
    Cappello AR; Curcio R; Lappano R; Maggiolini M; Dolce V
    Front Chem; 2018; 6():122. PubMed ID: 29719821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters.
    Pan CJ; Chen SY; Jun HS; Lin SR; Mansfield BC; Chou JY
    PLoS One; 2011; 6(9):e23157. PubMed ID: 21949678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
    Chou JY; Jun HS; Mansfield BC
    J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology and gene therapy for glycogen storage disease type Ib.
    Chou JY; Cho JH; Kim GY; Mansfield BC
    J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
    Chou JY; Matern D; Mansfield BC; Chen YT
    Curr Mol Med; 2002 Mar; 2(2):121-43. PubMed ID: 11949931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of type 1 glycogen storage diseases.
    Chou JY
    Curr Mol Med; 2001 Mar; 1(1):25-44. PubMed ID: 11899241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutropenia in type Ib glycogen storage disease.
    Chou JY; Jun HS; Mansfield BC
    Curr Opin Hematol; 2010 Jan; 17(1):36-42. PubMed ID: 19741523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.
    Chou JY; Jun HS; Mansfield BC
    Nat Rev Endocrinol; 2010 Dec; 6(12):676-88. PubMed ID: 20975743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic.
    Chen SY; Pan CJ; Nandigama K; Mansfield BC; Ambudkar SV; Chou JY
    FASEB J; 2008 Jul; 22(7):2206-13. PubMed ID: 18337460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
    Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
    Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.
    Chen LY; Pan CJ; Shieh JJ; Chou JY
    Hum Mol Genet; 2002 Dec; 11(25):3199-207. PubMed ID: 12444104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib.
    Kim SY; Jun HS; Mead PA; Mansfield BC; Chou JY
    Blood; 2008 Jun; 111(12):5704-11. PubMed ID: 18420828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent development and gene therapy for glycogen storage disease type Ia.
    Chou JY; Kim GY; Cho JH
    Liver Res; 2017 Sep; 1(3):174-180. PubMed ID: 29576889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of mutations in the glucose-6-phosphate transporter that cause glycogen storage disease type Ib.
    Chen SY; Pan CJ; Lee S; Peng W; Chou JY
    Mol Genet Metab; 2008 Dec; 95(4):220-3. PubMed ID: 18835800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
    Hiraiwa H; Pan CJ; Lin B; Akiyama TE; Gonzalez FJ; Chou JY
    J Biol Chem; 2001 Mar; 276(11):7963-7. PubMed ID: 11121425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia.
    Lee YM; Kim GY; Pan CJ; Mansfield BC; Chou JY
    Mol Genet Metab Rep; 2015 Jun; 3():28-32. PubMed ID: 26937391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the organisation and intracellular localisation of the two subunits of glucose-6-phosphatase.
    Soty M; Chilloux J; Casteras S; Grichine A; Mithieux G; Gautier-Stein A
    Biochimie; 2012 Mar; 94(3):695-703. PubMed ID: 21983240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human sugar-phosphate/phosphate exchanger family SLC37.
    Bartoloni L; Antonarakis SE
    Pflugers Arch; 2004 Feb; 447(5):780-3. PubMed ID: 12811562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.